The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-amino-4-(1H-indol-2-yl)-5-oxo-4,5-dihydropyrano[3,2-c]chromene-3-carbonitrile ID: ALA4878037
Cas Number: 879594-40-8
PubChem CID: 5306874
Max Phase: Preclinical
Molecular Formula: C21H13N3O3
Molecular Weight: 355.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: N#CC1=C(N)Oc2c(c(=O)oc3ccccc23)C1c1c[nH]c2ccccc12
Standard InChI: InChI=1S/C21H13N3O3/c22-9-13-17(14-10-24-15-7-3-1-5-11(14)15)18-19(27-20(13)23)12-6-2-4-8-16(12)26-21(18)25/h1-8,10,17,24H,23H2
Standard InChI Key: QXQIFLPSSMVVTR-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
27.5067 -3.9166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5055 -4.7440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2203 -5.1569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2186 -3.5038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9340 -3.9130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9327 -4.7460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6496 -5.1613 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.3723 -4.7481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6520 -3.4952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3734 -3.9187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0968 -3.5080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1053 -2.6721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3839 -2.2486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6541 -2.6610 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.0856 -5.1626 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.3906 -1.4237 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.8212 -2.2681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5392 -1.8617 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.8045 -3.9227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8838 -4.7439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6906 -4.9193 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.5611 -3.5937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1055 -4.2124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9115 -4.0496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1741 -3.2687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6246 -2.6503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8206 -2.8162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 9 1 0
6 7 1 0
7 8 1 0
8 10 1 0
9 10 2 0
9 14 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
8 15 2 0
13 16 1 0
17 18 3 0
12 17 1 0
19 20 2 0
20 21 1 0
22 19 1 0
11 19 1 0
23 21 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 355.35Molecular Weight (Monoisotopic): 355.0957AlogP: 3.49#Rotatable Bonds: 1Polar Surface Area: 105.04Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.85CX LogP: 2.34CX LogD: 2.34Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.51Np Likeness Score: -0.52
References 1. Sarkate AP, Dofe VS, Tiwari SV, Lokwani DK, Karnik KS, Kamble DD, Ansari MHSH, Dodamani S, Jalalpure SS, Sangshetti JN, Azad R, Burra PVLS, Bhandari SV.. (2021) One pot synthesis, in silico study and evaluation of some novel flavonoids as potent topoisomerase II inhibitors., 40 [PMID:33689875 ] [10.1016/j.bmcl.2021.127916 ]